Position in AMRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$13,761,448
+$1,551,423 QoQ
Shares Held
795,000
-19.1% QoQ
Ownership
0.249%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. AMRX ranks #14 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,398,674 | $1,078,432,506 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,981,234 | $236,524,202 | |
| 3 | ZTS |
Zoetis Inc.
|
2,624,825 | $188,619,917 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
4,766,781 | $165,264,292 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
275,358 | $149,197,220 | |
| 6 | VTRS |
Viatris Inc
|
7,322,267 | $116,277,595 | |
| 7 | HLN |
Haleon plc
|
10,824,395 | $100,991,599 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
699,229 | $77,572,458 |
All Filings in AMRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,761,448 | 795,000 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $12,210,025 | 982,303 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $8,349,351 | 662,647 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $7,719,759 | 771,205 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $10,778,839 | 1,332,366 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $9,148,360 | 1,091,690 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $9,622,577 | 1,214,972 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $10,791,820 | 1,297,094 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $3,298,987 | 519,526 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $2,558,063 | 422,123 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $1,129,268 | 186,041 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $2,476,122 | 586,759 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,650,841 | 532,530 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $438,317 | 315,337 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $611,013 | 307,042 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $745,300 | 368,961 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,190,594 | 374,401 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,515,314 | 363,385 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $1,736,498 | 362,526 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,000,758 | 374,674 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $2,062,514 | 402,835 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $2,854,205 | 424,102 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,228,660 | 487,672 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $143,455 | 36,973 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $159,850 | 33,582 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $135,646 | 38,979 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||